Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sartorius AGSARTF 88 Shiller PE Ratio is 45.67 as of Aug. 09, 2026, which is 57% below its 10-year median of 105.39. GuruFocus rates SARTF with a GF Score™ of 88/100 and a GF Value™ of $224.23 (Fairly Valued). The stock has 6 warning signs investors should review. Among 312 Medical Devices & Instruments companies, Sartorius AG ranks worse than 78.21% on this metric.
As of today (2026-08-09), Sartorius AG's current share price is $212.80. Sartorius AG's E10 for the quarter that ended in Jun. 2026 was $4.66. Sartorius AG's Shiller PE Ratio for today is 45.67.
The historical rank and industry rank for Sartorius AG's Shiller PE Ratio or its related term are showing as below:
SARTF'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 38.8 Med: 105.39 Max: 413.83
Current: 46.23
During the past years, Sartorius AG's highest Shiller PE Ratio was 413.83. The lowest was 38.80. And the median was 105.39.
SARTF's Shiller PE Ratio is ranked worse than 78.21% of 312
companies
in the Medical Devices & Instruments industry
Industry Median: 26.32
vs SARTF: 46.23
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Sartorius AG's adjusted earnings per share data for the three months ended in Jun. 2026 was $1.094. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $4.66 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Sartorius AG (OTCPK:SARTF) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Sartorius AG Shiller PE Ratio Related Terms
Sartorius AG Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for Sartorius AG's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SARTF vs ISRG, BDX, MDLN: Shiller PE Ratio Comparison
For the Medical Instruments & Supplies subindustry, Sartorius AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius AG Shiller PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Sartorius AG's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Sartorius AG's Shiller PE Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sartorius AG's E10 for the quarter that ended in Jun. 2026 is calculated as:
For example, Sartorius AG's adjusted earnings per share data for the three months ended in Jun. 2026 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Sartorius AG (SARTF) has a Shiller PE Ratio of 45.67 as of Aug. 09, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Sartorius AG and its competitors. This is 57% below median its historical median of 105.39. Over the past decade, Sartorius AG's Shiller PE Ratio has ranged from 38.80 to 413.83. According to the industry distribution chart, Sartorius AG ranks #244 out of 312 companies in the Medical Devices & Instruments industry, placing it in the top 78.2%.
Is Sartorius AG's Shiller PE Ratio too high?
Sartorius AG's current Shiller PE Ratio of 45.67 is 57% below median its 10-year median of 105.39. Over the past 10 years, this metric has ranged from a low of 38.80 to a high of 413.83. The Medical Devices & Instruments industry median Shiller PE Ratio is 26.32. Sartorius AG's value of 45.67 is 73.5% above this industry median. Based on the distribution chart, Sartorius AG ranks #244 out of 312 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sartorius AG has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's Shiller PE Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sartorius AG ranks #244 out of 312 companies for Shiller PE Ratio. This places Sartorius AG in the lower half of its industry. The industry median Shiller PE Ratio is 26.32. Sartorius AG's value of 45.67 is 73.5% above this benchmark. Historically, Sartorius AG's own Shiller PE Ratio has ranged from 38.80 to 413.83 over the past decade. While the company's 10-year median is 105.39 vs. the industry median of 26.32, Sartorius AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Medical Devices & Instruments company?
The median Shiller PE Ratio among Medical Devices & Instruments companies is 26.32, based on 312 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sartorius AG's current Shiller PE Ratio of 45.67 is 73.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Sartorius AG and its competitors. For the Medical Devices & Instruments industry, the median Shiller PE Ratio is 26.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sartorius AG's current Shiller PE Ratio is 45.67, which is 57% below median its own 10-year median of 105.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Based on GuruFocus' analysis, Sartorius AG (SARTF) is currently considered Fairly Valued. The stock's GF Value™ is $224.23, compared to a current price of $212.80 — trading 5.1% below its estimated fair value. The current Shiller PE Ratio is 45.67, which is 57% below median its 10-year median of 105.39 and 73.5% above the Medical Devices & Instruments industry median of 26.32. Sartorius AG's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Sartorius AG (SARTF), the current Shiller PE Ratio is 45.67 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sartorius AG (SARTF) Overvalued in 2026?
Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued.
The current stock price of $212.80 is trading 5.1% below its estimated GF Value™ of $224.23.
GuruFocus considers Sartorius AG to be Fairly Valued.
Key valuation signals for SARTF:
Shiller PE Ratio: 45.67 (57% below median its 10-year median of 105.39)
GF Value™: $224.23 vs. price of $212.80 (5.1% below fair value)
Industry Position: 73.5% above the Medical Devices & Instruments median (#244 of 312)
No single metric tells the full story. See the SARTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
88GF Score
Get the complete analysis for SARTF
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SARTF has been successfully added to your 
